Did you read about the revolutionary study of the statin drug, Crestor? A story in the LA Times (reprinted in the Star Tribune) was almost breathless in its praise:

According to new research, Crestor dramatically cut deaths, heart attacks and strokes in patients with healthy cholesterol levels but who had high levels of a protein associated with heart disease. The maker of Crestor, AstraZeneca, funded the study.

An international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis.